Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Avrobio Inc (NQ: AVRO )

3.590 USD -0.050 (-1.37%)
Streaming Delayed Price Updated: 4:00 PM EST, Dec 3, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 262,122
Open 3.700
Bid (Size) 3.510 (2)
Ask (Size) 4.190 (10)
Prev. Close 3.640
Today's Range 3.520 - 3.750
52wk Range 3.520 - 20.07
Shares Outstanding 43,652,470
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
AVROBIO Presents Clinician Experience with FAB-GT Clinical Trial and Updated Safety Data for Investigational Gene Therapies in Fabry Disease and Gaucher Disease Type 1
AVROBIO, Inc. (Nasdaq: AVRO), a leading clinical-stage gene therapy company with a vision to free people from a lifetime of genetic disease, today hosted a panel of investigators managing the patient... 
From Business Wire News Releases
AVROBIO to Present at Two Upcoming Investor Conferences in November
AVROBIO, Inc. (Nasdaq: AVRO), a leading clinical-stage gene therapy company with a mission to free people from a lifetime of genetic disease, today announced that members of its senior management team... 
From Business Wire News Releases

Performance

YTD
-75.36%
-75.36%
1 Month
-40.66%
-40.66%
3 Month
-42.74%
-42.74%
6 Month
-58.83%
-58.83%
1 Year
-73.19%
-73.19%

More News

Read More
AVROBIO to Present Clinical and Preclinical Data at the 14th ICIEM Conference
From Business Wire News Releases
AVROBIO Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
From Business Wire News Releases
AVROBIO Reports Third Quarter 2021 Financial Results and Provides Business Update
From Business Wire News Releases
AVROBIO Receives Rare Pediatric Disease Designation from the U.S. FDA for AVR-RD-05, a Gene Therapy for Mucopolysaccharidosis Type II (MPSII) or Hunter Syndrome
From Business Wire News Releases
AVROBIO Announces the Appointment of Essra Ridha, M.D., MRCP, FFPM, as Chief Medical Officer
From Business Wire News Releases
12 Health Care Stocks Moving In Friday's Intraday Session
Tags Market News Movers MRNA
From Benzinga
AVROBIO to Present at the Jefferies Virtual Gene Therapy/Editing Summit
From Business Wire News Releases
10 Top Penny Stocks To Watch This Week With Potential Biotech Catalysts
Tags Market News
From Penny Stocks to Buy, Picks, News and Information | PennyStocks.com - Feed
AVROBIO Reports New Interim Safety Data Across Investigational Gene Therapies for Fabry and Gaucher Disease Type 1
From Business Wire News Releases
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.